Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Sardine-enriched Diet for Prevention Type 2 Diabetes in Elderly and Prediabetic Population
NCT number | NCT03557541 |
Other study ID # | 2013/8863 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2014 |
Est. completion date | July 2017 |
Verified date | July 2018 |
Source | Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The hypothesis formulated is that 200 g of sardine on a weekly basis will have a favourable impact avoiding the natural development of the pathology due to changes in the biochemical profile, the anthropometrics, inflammatory markers, changes in gut microbiota populations, also in transcriptomics and metabolomics.
Status | Completed |
Enrollment | 182 |
Est. completion date | July 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - glycaemia between 100-125 md / dL or =5.7% HbA1c Exclusion Criteria: - treatment with oral antidiabetic drugs - any nutritional education to prevent T2D - Suspect or known hypersensitivity to sardine or related fish - Chronic treatment with oral steroids and / or AINES - Treatment with oral antidiabetic agents and / or insulin - Treatment with immunosuppressive drugs - Diagnosis of active neoplasm - Diagnosis of HIV or AIDS - Abnormal liver profile (> 6 times normal values) - Diagnosis of Acute Psychiatric Sdr - Presence of serious acute concomitant disease, which it requires more than 7 days of recovery. - Major cardiovascular event (stroke, myocardial infarction) in the month prior to randomization. - Any other condition that the investigator considers to be inoperative so that the subject conducts the study. |
Country | Name | City | State |
---|---|---|---|
Spain | Diana A Diaz Rizzolo | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Institut d'Investigacions Biomèdiques August Pi i Sunyer |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | type 2 diabetes new onset | incidence of new diagnosis of type 2 diabetes | Change from Baseline at 12 months | |
Secondary | adiponectin | adiponectin levels | Change from Baseline at 12 months | |
Secondary | quantification of gut microbiota populations | quantification by q-PCR | Change from Baseline at 12 months | |
Secondary | gene expression | relative expression related genes by RT q-PCR (Real Time Quantitative Reverse transcription polymerase chain reaction) | Change from Baseline at 12 months | |
Secondary | metabolomics study of dietary biomarkers and health biomarkers [(1) Fatty acyls, bile acids, steroids and lysoglycerophospholipids, (2) Glycerolipids, glycerophospholipids, sterol lipids and sphingolipids, (3) Amino acids.] | endogenous metabolic profiles of serum samples will be studied using ultra-high performance liquid chromatography - mass spectrometry (UHPLC-MS). The same unit for measurements [log2 (fold change)] | Change from Baseline at 12 months | |
Secondary | glucose homeostasis | glucose (mg/dl) | Change from Baseline at 12 months | |
Secondary | insulin levels | insulin (mU/L) | Change from Baseline at 12 months | |
Secondary | HOMA-IR (homeostasis model assessment insulin resistance) | insulin resistance index | Change from Baseline at 12 months | |
Secondary | HOMA-B (homeostasis model assessment B cell function) | B cella function | Change from Baseline at 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |